Synergistic Probiotic-AI-IoT-Blockchain System for Enhanced Antiviral Effects
Legal Citation
Summary of the Inventive Concept
A novel system integrating probiotic bacterial molecules with AI, IoT, and blockchain technologies to prevent and treat viral infections in mammals, providing real-time monitoring, optimized treatment regimens, and decentralized data storage.
Background and Problem Solved
The original patent disclosed antiviral methods and compositions comprising probiotic bacterial molecules. However, the patent's limitations included the lack of real-time monitoring, data analysis, and decentralized storage. The new inventive concept addresses these limitations by integrating probiotic molecules with AI, IoT, and blockchain technologies to create a more powerful and efficient system.
Detailed Description of the Inventive Concept
The synergistic system comprises a probiotic bacterial molecule-based composition, an AI-powered monitoring device, an IoT-enabled wearable device, and a blockchain-secured decentralized data storage platform. The AI module analyzes real-time data from the IoT device and blockchain network to optimize treatment regimens and predict viral outbreaks. The probiotic molecules are released in response to changes in viral loads, and the blockchain platform provides secure, decentralized data storage and real-time recommendations for treatment.
Novelty and Inventive Step
The new claims introduce the innovative combination of probiotic molecules with AI, IoT, and blockchain technologies, providing a non-obvious and novel solution for preventing and treating viral infections. The integration of these distinct technologies enables real-time monitoring, optimized treatment regimens, and decentralized data storage, which is not taught by the original patent.
Alternative Embodiments and Variations
Alternative embodiments may include the use of different AI algorithms, IoT device configurations, or blockchain platforms. Variations may include the integration of additional technologies, such as nanomaterial-based delivery systems or novel materials, to further enhance the system's efficiency and effectiveness.
Potential Commercial Applications and Market
The synergistic system has significant commercial potential in the healthcare and biotechnology industries, particularly in the development of personalized medicine and precision health. The system's ability to provide real-time monitoring and optimized treatment regimens makes it an attractive solution for hospitals, clinics, and healthcare providers.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biotechnology and medical microbiology, with expertise in probiotic bacterial compositions, viral infection treatment, and emerging digital health technologies
Person of Ordinary Skill (PHOSITA) Profile
A researcher or practitioner with advanced degrees in microbiology, biotechnology, or biomedical engineering, possessing knowledge of probiotic bacterial interactions, viral infection mechanisms, and emerging digital health integration techniques
Obviousness Rationale
A PHOSITA would recognize that integrating digital monitoring technologies with existing probiotic-based antiviral treatments represents a predictable extension of known medical technology. The combination of probiotic bacterial molecules with AI, IoT, and blockchain technologies follows established patterns of digital health innovation. The core antiviral mechanism from the source patent remains fundamentally unchanged, with technological monitoring and optimization layers added as a natural progression of medical treatment approaches.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,581 |
|---|---|
| Title | Antiviral methods and compositions comprising probiotic bacterial molecules |
| Assignee(s) | MICROSINTESIS INC. |